Continuing Education

Background: Public health campaigns aimed at reducing the morbidity, mortality and economic burden of atherosclerotic cardiovascular disease (ASCVD) have mainly

Introduction: Uninsurance is a known contributor to racial/ethnic minority health inequities. Insurance is needed for prescription medications and follow-up visits

Despite a 27% reduction in all-cause mortality from targeting a systolic blood pressure of &lt 120 mm Hg, as compared

Introduction: Real-world data describing acute pericarditis (AP) etiology in the US are limited. Data on the characteristics of recurrent pericarditis

Background: Myocardial infarction after non-cardiac surgery is common and associated with worse patient outcomes. In 2017, the Canadian Cardiovascular Society

Introduction: Uninsurance is a known contributor to racial/ethnic minority health inequities. Insurance is needed for prescription medications and follow-up visits

Background: In the 2018 AHA/ACC Blood Cholesterol Guideline, it is recommended that ASCVD patients be classified as very high-risk (VHR)

Background: The NCDR Cath/PCI Registry provides standardized capture of cardiovascular and anatomic risk factors and national benchmarking of outcomes to

Introduction: Atherosclerotic cardiovascular disease (ASCVD) is one of the leading causes of morbidity and mortality worldwide. There have been many

A sedentary lifestyle has long been recognized as a risk factor for heart disease. Although little data exists on the